Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

University of Calgary

$668,930.00

Role of Ryanodine Receptor in Cardiac Alternans and Ventricular Fibrillation

EF 2011-12

Résumé
In the heart, muscle contraction is triggered by the release of calcium from the internal calcium stores called the sarcoplasmic reticulum, whereas muscel relaxation is achieved by moving the released calcium back to the the stores. To ensure stable muscle contraction and relaxation, i.e. heart beats, calcium release and reuptake must be precisely controlled. However, in some pathological settings, this calcium cycling is disturbed, leading to alternating changes in calcium release and musche contraction in a beat-to-beat basis, a phenomenon known as calcium alternans that can cause electrical alternans in the heart, resulting in irregular heart beats and sudden death. At the moment, the mechanism underlying these beat-to-beat variations is unclear. The objective of this research proposal is to investigate how alternating changes in calcium release occurs and how defects in the calcium release channel lead to calcium release alternations and irregular heart beats. Recent studies from Dr. Chen's laboratory have provided some important clues to these fundamental questions. A variety of cutting-edge technologies will be employed to study the role of the channel in controlling calcium release and how this process is affected by disease-causing mutations in the channel. These proposed studies will shed novel and exciting insights into the molecular basis and regulation of Ca2+ release, and have profound implications for the prevention and treatment of various heart diseases.
Programme
Operating Grant
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
254537
Name
Chen Sui Rong W
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Cardiovascular System - A: Cells and Tissues
Projecttitle
Role of Ryanodine Receptor in Cardiac Alternans and Ventricular Fibrillation
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$668,930
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Calcium Imaging; Cardiac Arrhythmias; Cardiomyopathies; Disease Mutations; Excitation-Contraction Coupling; Ryanodine Receptor; Single Channel Recordings; Sr Calcium Release; Structure And Function
Abstract
In the heart, muscle contraction is triggered by the release of calcium from the internal calcium stores called the sarcoplasmic reticulum, whereas muscel relaxation is achieved by moving the released calcium back to the the stores. To ensure stable muscle contraction and relaxation, i.e. heart beats, calcium release and reuptake must be precisely controlled. However, in some pathological settings, this calcium cycling is disturbed, leading to alternating changes in calcium release and musche contraction in a beat-to-beat basis, a phenomenon known as calcium alternans that can cause electrical alternans in the heart, resulting in irregular heart beats and sudden death. At the moment, the mechanism underlying these beat-to-beat variations is unclear. The objective of this research proposal is to investigate how alternating changes in calcium release occurs and how defects in the calcium release channel lead to calcium release alternations and irregular heart beats. Recent studies from Dr. Chen's laboratory have provided some important clues to these fundamental questions. A variety of cutting-edge technologies will be employed to study the role of the channel in controlling calcium release and how this process is affected by disease-causing mutations in the channel. These proposed studies will shed novel and exciting insights into the molecular basis and regulation of Ca2+ release, and have profound implications for the prevention and treatment of various heart diseases.
Competitiondate
201203
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Chen, Sui Rong W
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $668,930~ $0~